TOTM

Testimony on HB 1902 Prohibiting “Pay for Delay” Settlements

David Fischer brings my attention to testimony on HB 1902 which would prohibit “payment for delay” settlements between brand name and generic drug companies.  FTC Commissioner Leibowitz testified on the position of my new employer here.

Read the full piece here